Dow (DOW) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
3 Feb, 2026Executive summary
Q4 2025 operating EBITDA was $741 million, reflecting a sequential decline due to lower seasonal demand and margin compression, but over $165 million in cost savings and more than half of $6.5 billion in near-term cash support actions were delivered.
Full-year 2025 net sales reached $40.0 billion, with operating EBITDA of $3.3 billion and $1.5 billion returned to shareholders.
The Transform to Outperform program targets at least $2 billion in near-term EBITDA improvement, with $500 million expected in 2026 and two-thirds from productivity.
Path2Zero project in Alberta delayed to late 2029 to align with market recovery, with phase one startup now targeted for year-end 2029.
CEO highlighted progress on cost and cash support actions, with a focus on further productivity and earnings improvements.
Financial highlights
Q4 2025 operating EBITDA was $741 million, down $464 million year-over-year, with net sales of $9.5 billion, down 9% year-over-year and 5% sequentially.
Packaging and Specialty Plastics segment Q4 net sales were $4.7 billion, with a 2% volume decrease year-over-year; operating EBIT was $215 million.
Industrial Intermediates and Infrastructure segment Q4 net sales were $2.7 billion, down 9% year-over-year; operating EBIT loss of $201 million.
Performance Materials and Coatings segment Q4 net sales were $1.9 billion, down 6% year-over-year; operating EBIT $25 million, up $34 million year-over-year.
Cash and cash equivalents at year-end exceeded $3.8 billion, with $14 billion in available liquidity.
Outlook and guidance
Q1 2026 EBITDA expected to be approximately $750 million, reflecting margin expansion and seasonal uplift, with net sales projected at ~$9.4 billion.
Transform to Outperform program expected to deliver $500 million in EBITDA uplift in 2026 and $1 billion in annual benefits from ongoing initiatives.
FY26 modeling includes $50–$150 million lower equity earnings year-over-year, $65 million higher pension impact, and $200 million higher turnaround expenses.
Expects continued cost savings and productivity improvements, but higher planned turnaround spending will offset some gains.
Latest events from Dow
- Proxy seeks approval for director elections, pay, plan amendment, and auditor, with ESG focus.DOW
Proxy Filing18 Mar 2026 - Record sales, tight supply, and $1B+ savings drive margin gains amid global volatility.DOW
JPMorgan Industrials Conference 202618 Mar 2026 - Board seeks approval for SIP amendment, director elections, and auditor ratification at 2026 meeting.DOW
Proxy Filing17 Mar 2026 - Board recommends voting for all proposals, highlighting governance, pay-for-performance, and ESG.DOW
Proxy Filing27 Feb 2026 - Key 2026 proposals include director elections, say-on-pay, and auditor ratification.DOW
Proxy Filing27 Feb 2026 - Annual meeting to vote on directors, compensation, stock plan, and auditor ratification.DOW
Proxy Filing27 Feb 2026 - Q2 2024 net sales fell 4% to $10.9B, with sequential earnings growth and strong cash returns.DOW
Q2 20243 Feb 2026 - Strategic investments and resilient packaging offset near-term headwinds, supporting long-term growth.DOW
Morgan Stanley‘s 12th Annual Laguna Conference 202420 Jan 2026 - Q3 sales up 1% to $10.9B, net income and margins down, asset actions and investments ongoing.DOW
Q3 202418 Jan 2026